| Kaye Lynn Unrein, FNP-C | |
|
3514 21st St Fl 6, Lubbock, TX 79410-1210 | |
| (806) 725-2263 | |
| (806) 723-7768 |
| Full Name | Kaye Lynn Unrein |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 3514 21st St Fl 6, Lubbock, Texas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033701271 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 1011293 (Texas) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | 1011293 (Texas) | Primary |
| Entity Name | Covenant Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376598904 PECOS PAC ID: 6901889393 Enrollment ID: O20040608000563 |
News Archive
Results from the HEBE III study, a prospective, randomised, multicentre trial performed in seven centres in the Netherlands, suggest that the promising effects of erythropoieitin seen in previous smaller studies cannot be confirmed for the improvement of clinical outcome in patients with a first ST-elevation myocardial infarction.
Summer months are just on the horizon bringing wonderful warm days filled with sunshine. For most parents, sending kids outside to play includes lathering them with sunscreen to protect their skin from too much of the sun's UVA and UVB rays, but what about protecting their children's eyes?
A therapeutic cancer vaccine being co-developed by the Ludwig Institute for Cancer Research and the Australian biotech company CSL Limited successfully induced a comprehensive immune response in patients and appeared to delay cancer recurrence
Zimmer Holdings, Inc. today reported financial results for the quarter and year ended December 31, 2012. The Company reported fourth quarter net sales of $1.18 billion, an increase of 1.1% reported and 2.1% constant currency over the fourth quarter of 2011.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kaye Lynn Unrein, FNP-C 2215 Nashville Ave, Lubbock, TX 79410-1105 Ph: (806) 725-5844 | Kaye Lynn Unrein, FNP-C 3514 21st St Fl 6, Lubbock, TX 79410-1210 Ph: (806) 725-2263 |
News Archive
Results from the HEBE III study, a prospective, randomised, multicentre trial performed in seven centres in the Netherlands, suggest that the promising effects of erythropoieitin seen in previous smaller studies cannot be confirmed for the improvement of clinical outcome in patients with a first ST-elevation myocardial infarction.
Summer months are just on the horizon bringing wonderful warm days filled with sunshine. For most parents, sending kids outside to play includes lathering them with sunscreen to protect their skin from too much of the sun's UVA and UVB rays, but what about protecting their children's eyes?
A therapeutic cancer vaccine being co-developed by the Ludwig Institute for Cancer Research and the Australian biotech company CSL Limited successfully induced a comprehensive immune response in patients and appeared to delay cancer recurrence
Zimmer Holdings, Inc. today reported financial results for the quarter and year ended December 31, 2012. The Company reported fourth quarter net sales of $1.18 billion, an increase of 1.1% reported and 2.1% constant currency over the fourth quarter of 2011.
› Verified 9 days ago